Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Clinical trial NCT00923936 · COMPLETED
Trial details
- NCT number
- NCT00923936
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-23
- Primary completion
- 2015-05-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.